CRISPR-mediated targeting of HER2 inhibits cell proliferation through a dominant negative mutation.

Wang H, Sun W
Cancer Lett. 2017 Jan 28;385:137-143. doi: 10.1016/j.canlet.2016.10.033. Epub 2016 Nov 1. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.